T lymphocytes

Critical Care Medicine

Volumn 33, Issue 12 SUPPL., 2005, Pages

  Ochoa, Juan B ^a   Makarenkova, Valeriya ^a  

^a UNIVERSITY OF PITTSBURGH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; CYTOKINE; GAMMA INTERFERON; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 6; INTERLEUKIN 9; OMEGA 3 FATTY ACID; TRANSFORMING GROWTH FACTOR BETA;

CELL FUNCTION; CELLULAR IMMUNITY; CRITICAL ILLNESS; CYTOKINE PRODUCTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INJURY; INNATE IMMUNITY; LYMPHOCYTE PROLIFERATION; NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; SEPSIS; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TH1 CELL; TH2 CELL; UPREGULATION;

EID: 28944455488     PISSN: 00903493     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.CCM.0000186788.71460.53     Document Type: Article

References (28)

1. Mannick JA, Rodrick ML, Lederer JA: The immunologic response to injury. J Am Coll Surg 2001; 193:237
2. Matzinger P: The danger model: A renewed sense of self. Science 2002; 296:301
3. Paul WE (Ed): TH1/TH2 cells: The T Helper Paradigm. Philadelphia, Lippincott Williams & Wilkins, 2003
4. Abbas AK, Lichtman AH (Eds): Antigen processing and presentation by T lymphocytes. In: Cellular and Molecular Immunology. Philadelphia, Saunders, 2005, p. 81
5. Monteleone G, MacDonald TT: Manipulation of cytokines in the management of patients with inflammatory bowel disease. Ann Med 2000; 32:552
6. Murphy TJ, Choileain NN, Zang Y, et al: CD4+CD25+ regulatory T cells control innate immune reactivity after injury. J Immunol 2005; 174:2957
7. Murphy T, Paterson H, Rogers S, et al: Use of intracellular cytokine staining and bacterial superantigen to document suppression of the adaptive immune system in injured patients. Ann Surg 2003; 238:401
8. Wahl SM, Swisher J, Cartney-Francis N, et al: TGF-beta: The perpetrator of immune suppression by regulatory T cells and suicidal T cells. J Leukoc Biol 2004; 76:15
9. De AK, Kodys K, Puyana JC, et al: Only a subset of trauma patients with depressed mitogen responses have true T cell dysfunctions. Clin Immunol Immunopathol 1997; 82:73
10. De AK, Laudanski K, Miller-Graziano CL: Failure of monocytes of trauma patients to convert to immature dendritic cells is related to preferential macrophage-colony-stimulating factor-driven macrophage differentiation. J Immunol 2003; 170:6355
11. Walsh DS, Siritongtaworn P, Pattanapanyasat K, et al: Lymphocyte activation after non-thermal trauma. Br J Surg 2000; 87:223
12. Spolarics Z, Siddiqi M, Siegel JH, et al: Depressed interleukin-12- producing activity by monocytes correlates with adverse clinical course and a shift toward Th2-type lymphocyte pattern in severely injured male trauma patients. Crit Care Med 2003; 31:1722
13. Ochoa JB, Bernard AC, O'Brien WE, et al: Arginase I expression and activity in human mononuclear cells after injury. Ann Surg 2001; 233:393
14. Tsuei BJ, Bernard AC, Shane MD, et al: Surgery induces human mononuclear cell arginase I expression. J Trauma 2001; 51:497
15. Bronte V, Serafini P, Mazzoni A, et al: L-arginine metabolism in myeloid cells controls T-lymphocyte functions. Trends Immunol 2003; 24:302
16. Ichihara F, Kono K, Sekikawa T, et al: Surgical stress induces decreased expression of signal-transducing zeta molecules in T cells. Eur Surg Res 1999; 31:138
17. Ochoa AC, Longo DL: Alteration of signal transduction in T cells from cancer patients. Important Adv Oncol 1995; 43
18. Zea AH, Ochoa MT, Ghosh P, et al: Changes in expression of signal transduction proteins in T lymphocytes of patients with leprosy. Infect Immun 1998; 66:499
19. Bansal V, Ochoa JB: Arginine availability, arginase, and the immune response. Curr Opin Clin Nutr Metab Care 2003; 6:223
20. Ono S, Ueno C, Seki S, et al: Interleukin-12 and -18 induce severe liver injury in mice recovered from peritonitis after sublethal endotoxin challenge. Surgery 2003; 134:92
21. Lainee P, Efron P, Tschoeke SK, et al: Delayed neutralization of interferon-gamma prevents lethality in primate Gram-negative bacteremic shock. Crit Care Med 2005; 33:797
22. Watanabe H, Numata K, Ito T, et al: Innate immune response in Th1- and Th2-dominant mouse strains. Shock 2004; 22:460
23. Sasaki T, Mieno M, Udono H, et al: Roles of CD4+ and CD8+ cells, and the effect of administration of recombinant murine Interferon gamma in listerial infection. J Exp Med 1990; 171:1141
24. Vasconcelos JR, Hiyane MI, Marinho CR, et al: Protective immunity against trypanosoma cruzi infection in a highly susceptible mouse strain after vaccination with genes encoding the amastigote surface protein-2 and transsialidase. Hum Gene Ther 2004; 15:878
25. Venet F, Pachot A, Debard AL, et al: Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+. Crit Care Med 2004; 32:2329
26. Lainee P, Efron P, Tschoeke SK, et al: Delayed neutralization of interferon-gamma prevents lethality in primate Gram-negative bacteremic shock. Crit Care Med 2005; 33:797
27. Heyland DK, Novak F, Drover JW, et al: Should immunonutrition become routine in critically ill patients? A systematic review of the evidence. JAMA 2001; 286:944
28. Ochoa JB, Makarenkova V, Bansal V: A rational use of immune enhancing diets: When should we use dietary arginine supplementation? NCP 2004; 19:216